The FDA has approved an implantable neurostimulation system designed for the treatment of intractable chronic low back pain associated with multifidus muscle dysfunction.
After results from a clinical trial demonstrated its safety and efficacy, the US Food and Drug Administration recently approved the first and only extended-release intra-articular injection for patients...
